Tarsons Products [TARSONS] vs Prevest Denpro [PREVEST] Detailed Stock Comparison

Tarsons Products
NSE
Loading...

Prevest Denpro
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Tarsons Products wins in 6 metrics, Prevest Denpro wins in 11 metrics, with 0 ties. Prevest Denpro appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Tarsons Products | Prevest Denpro | Better |
---|---|---|---|
P/E Ratio (TTM) | 63.57 | 35.41 | Prevest Denpro |
Price-to-Book Ratio | 2.78 | 6.08 | Tarsons Products |
Debt-to-Equity Ratio | 53.82 | 0.00 | Prevest Denpro |
PEG Ratio | -1.16 | N/A | N/A |
EV/EBITDA | 18.41 | 22.23 | Tarsons Products |
Profit Margin (TTM) | 6.90% | 28.73% | Prevest Denpro |
Operating Margin (TTM) | 5.22% | 35.36% | Prevest Denpro |
EBITDA Margin (TTM) | 5.22% | 35.36% | Prevest Denpro |
Return on Equity | 4.72% | 17.20% | Prevest Denpro |
Return on Assets (TTM) | 2.76% | 16.13% | Prevest Denpro |
Free Cash Flow (TTM) | $-374.69M | $128.49M | Prevest Denpro |
Dividend Yield | 0.53% | N/A | N/A |
1-Year Return | -28.78% | -4.92% | Prevest Denpro |
Price-to-Sales Ratio (TTM) | 4.40 | 9.77 | Tarsons Products |
Enterprise Value | $20.91B | $5.81B | Tarsons Products |
EV/Revenue Ratio | 5.24 | 9.22 | Tarsons Products |
Gross Profit Margin (TTM) | 67.93% | 86.70% | Prevest Denpro |
Revenue per Share (TTM) | $75 | $55 | Tarsons Products |
Earnings per Share (Diluted) | $5.19 | $15.11 | Prevest Denpro |
Beta (Stock Volatility) | 0.11 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Tarsons Products vs Prevest Denpro Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Tarsons Products | -0.15% | -3.72% | -14.71% | -13.52% | 9.94% | -19.25% |
Prevest Denpro | 3.32% | 3.19% | -2.87% | 23.64% | 28.42% | -6.24% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Tarsons Products | -28.78% | -57.67% | -59.98% | -59.98% | -59.98% | -59.98% |
Prevest Denpro | -4.92% | 38.76% | 112.28% | 112.28% | 112.28% | 112.28% |
Performance & Financial Health Analysis: Tarsons Products vs Prevest Denpro
Metric | TARSONS | PREVEST |
---|---|---|
Market Information | ||
Market Cap | ₹17.56B | ₹6.42B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 101,601 | 5,240 |
90 Day Avg. Volume | 56,632 | 9,927 |
Last Close | ₹327.50 | ₹562.55 |
52 Week Range | ₹280.00 - ₹491.80 | ₹393.60 - ₹686.00 |
% from 52W High | -33.41% | -18.00% |
All-Time High | ₹924.90 (Nov 29, 2021) | ₹686.00 (Jan 13, 2025) |
% from All-Time High | -64.59% | -18.00% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.08% | 0.27% |
Quarterly Earnings Growth | -0.56% | 0.20% |
Financial Health | ||
Profit Margin (TTM) | 0.07% | 0.29% |
Operating Margin (TTM) | 0.05% | 0.35% |
Return on Equity (TTM) | 0.05% | 0.17% |
Debt to Equity (MRQ) | 53.82 | 0.00 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹118.59 | ₹87.96 |
Cash per Share (MRQ) | ₹4.89 | N/A |
Operating Cash Flow (TTM) | ₹571.91M | ₹185.37M |
Levered Free Cash Flow (TTM) | ₹297.70M | ₹181.55M |
Dividends | ||
Last 12-Month Dividend Yield | 0.53% | N/A |
Last 12-Month Dividend | ₹2.00 | N/A |
Valuation & Enterprise Metrics Analysis: Tarsons Products vs Prevest Denpro
Metric | TARSONS | PREVEST |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 63.57 | 35.41 |
Forward P/E | 26.61 | N/A |
PEG Ratio | -1.16 | N/A |
Price to Sales (TTM) | 4.40 | 9.77 |
Price to Book (MRQ) | 2.78 | 6.08 |
Market Capitalization | ||
Market Capitalization | ₹17.56B | ₹6.42B |
Enterprise Value | ₹20.91B | ₹5.81B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.24 | 9.22 |
Enterprise to EBITDA | 18.41 | 22.23 |
Risk & Other Metrics | ||
Beta | 0.11 | N/A |
Book Value per Share (MRQ) | ₹118.59 | ₹87.96 |
Financial Statements Comparison: Tarsons Products vs Prevest Denpro
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | TARSONS | PREVEST |
---|---|---|
Revenue/Sales | ₹913.64M | ₹184.55M |
Cost of Goods Sold | ₹293.05M | ₹24.54M |
Gross Profit | ₹620.59M | ₹160.01M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹47.67M | ₹60.76M |
EBITDA | ₹280.39M | ₹76.23M |
Pre-Tax Income | ₹30.32M | ₹71.51M |
Income Tax | ₹12.49M | ₹20.16M |
Net Income (Profit) | ₹17.83M | ₹51.41M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | TARSONS | PREVEST |
---|---|---|
Cash & Equivalents | ₹251.31M | ₹608.98M |
Total Current Assets | ₹2.43B | ₹857.16M |
Total Current Liabilities | ₹1.76B | ₹59.62M |
Long-Term Debt | ₹2.12B | ₹0 |
Total Shareholders Equity | ₹6.30B | ₹1.06B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹4.72B | ₹268.13M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | TARSONS | PREVEST |
---|---|---|
Operating Cash Flow | ₹100.02M | N/A |
Capital Expenditures | ₹-279.63M | N/A |
Free Cash Flow | ₹-231.27M | N/A |
Debt Repayment | ₹-754.90M | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | TARSONS | PREVEST |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 101,601 | 5,240 |
Average Daily Volume (90 Day) | 56,632 | 9,927 |
Shares Outstanding | 53.21M | 12.00M |
Float Shares | 13.20M | 2.61M |
% Held by Insiders | 0.75% | 0.78% |
% Held by Institutions | 0.08% | 0.00% |
Dividend Analysis & Yield Comparison: Tarsons Products vs Prevest Denpro
Metric | TARSONS | PREVEST |
---|---|---|
Last 12-Month Dividend | ₹2.00 | N/A |
Last 12-Month Dividend Yield | 0.53% | N/A |
3-Year Avg Annual Dividend | ₹0.67 | N/A |
3-Year Avg Dividend Yield | 0.46% | N/A |
3-Year Total Dividends | ₹2.00 | N/A |
Ex-Dividend Date | Sep 20, 2024 | N/A |